The phenomenon of ischaemic preconditioning (IPC) is clinically very important, being involved in the potential protection of myocardium during cardiac surgery or percutaneous invasive procedures. However, its precise mechanisms have not yet been established. It is commonly known that patients with either diabetes or heart failure do not benefit from IPC in a similar extent to subjects without these metabolic pathologies.
Ironresource.org is a non-promotional, educational resource exclusively available to healthcare professionals working in iron therapy from a host of therapeutic areas.
Ironresource.org is an educational programme funded by Vifor (International) Inc. All content is independently generated by the Ironresource.org faculty experts reflecting their knowledge and opinions.